Home » Posts tagged with » Fiona Marshall
Yumanity secures $500m worth deal with Merck to develop therapies for neurodegenerative disorders

Yumanity secures $500m worth deal with Merck to develop therapies for neurodegenerative disorders

Massachusetts-based Yumanity Therapeutics has secured a drug development deal worth up to nearly $500 million with pharma giant Merck to develop new therapies for neurodegenerative disorders. The partnership is set to combine the drug discovery platform of Yumanity Therapeutics with the development and commercialization expertise in neuroscience of Merck. As per the deal, Merck will […]

Merck acquires Calporta Therapeutics from COI Pharmaceuticals

Merck acquisition of Calporta : Merck has acquired Calporta Therapeutics from COI Pharmaceuticals in a deal worth up to $576 million, as per the latest pharma acquisition news. Calporta Therapeutics, which was launched in early 2015, is engaged in the development of selective small-molecule agonists to TRPML1. According to COI Pharmaceuticals, TRPML1 is thought to […]

Continue reading …